Société Urovant Sciences Ltd.
Actions
UROV
BMG9381B1081
Recherche biotechnologique et médicale
Métier
Nombre d'employés: 70
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
James Robinson
CEO | Chief Executive Officer | 54 | 01/03/19 |
Ajay Bansal
DFI | Director of Finance/CFO | 62 | 28/10/19 |
Chief Tech/Sci/R&D Officer | 66 | - | |
Ryan Kubota
IRC | Investor Relations Contact | - | - |
Kenton Stewart
SAM | Sales & Marketing | - | 02/06/20 |
Nori Ebersole
HRO | Human Resources Officer | 60 | 01/12/17 |
Walt Johnston
PRN | Corporate Officer/Principal | - | 02/06/20 |
Christine Ocampo
AUD | Comptroller/Controller/Auditor | 51 | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
James Hindman
BRD | Director/Board Member | 63 | 20/05/20 |
Sef P. Kurstjens
BRD | Director/Board Member | 60 | 01/07/18 |
James Robinson
CEO | Chief Executive Officer | 54 | 01/03/19 |
Director/Board Member | 59 | 27/12/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 32 743 396 | 5 633 501 ( 17,20 %) | 0 | 17,20 % |
Coordonnées société
Urovant Sciences Ltd.
11-12 Saint James's Square Suite 1
SW1Y 4LB, London
+
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+8,96% | 105 Md | |
-1,43% | 104 Md | |
+4,40% | 22,94 Md | |
-12,15% | 22,34 Md | |
-4,36% | 19,25 Md | |
-39,98% | 17,08 Md | |
-10,04% | 16,96 Md | |
+6,79% | 14,16 Md | |
+38,61% | 12,63 Md |